Page last updated: 2024-09-03

(tetrazol-5-yl)glycine and Seizures

(tetrazol-5-yl)glycine has been researched along with Seizures in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, GE; Farrington, JS; Inada, K; Koller, BH1
Leander, JD; Lodge, D; Lunn, WH; Millar, JD; Sacaan, AI; Schoepp, DD; Smith, CL1

Other Studies

2 other study(ies) available for (tetrazol-5-yl)glycine and Seizures

ArticleYear
Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.
    Brain research, 2008, Jul-24, Volume: 1221

    Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Excitatory Amino Acid Agonists; Female; Genetic Predisposition to Disease; Glutamic Acid; Glycine; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Proto-Oncogene Proteins c-fos; Receptors, N-Methyl-D-Aspartate; Seizures; Septal Nuclei; Solitary Nucleus; Synaptic Transmission; Tetrazoles

2008
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
    European journal of pharmacology, 1991, Oct-15, Volume: 203, Issue:2

    Topics: Animals; Binding, Competitive; Cerebral Cortex; Glutamates; Glutamic Acid; Glycine; Kinetics; Male; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles; Tritium

1991